188 related articles for article (PubMed ID: 18785286)
1. Halothane hepatitis in Iran: a review of 59 cases.
Eghtesadi-Araghi P; Sohrabpour A; Vahedi H; Saberi-Firoozi M
World J Gastroenterol; 2008 Sep; 14(34):5322-6. PubMed ID: 18785286
[TBL] [Abstract][Full Text] [Related]
2. Isoflurane hepatotoxicity in a patient with a previous history of halothane-induced hepatitis.
Hasan F
Hepatogastroenterology; 1998; 45(20):518-22. PubMed ID: 9638441
[TBL] [Abstract][Full Text] [Related]
3. Exposure Assessment, Biological Monitoring, and Liver Function Tests of Operating Room Personnel Exposed to Halothane in Hamedan Hospitals, West of Iran.
Bakhshaei MH; Bahrami A; Mirzakhani A; Mahjub H; Assari MJ
J Res Health Sci; 2017 Nov; 17(4):e00397. PubMed ID: 29233951
[TBL] [Abstract][Full Text] [Related]
4. Halothane and post-halothane exposure hepatitis.
Buchanan CC; Cameron RJ; Carpenter RD; Currie J; Spencer HT
N Z Med J; 1999 Jan; 112(1080):19-20. PubMed ID: 10073163
[No Abstract] [Full Text] [Related]
5. Halothane-induced acute liver failure: continuing occurrence and use of liver transplantation.
Lo SK; Wendon J; Mieli-Vergani G; Williams R
Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):635-9. PubMed ID: 9744690
[TBL] [Abstract][Full Text] [Related]
6. Halothane hepatitis.
Neuberger J
Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):631-3. PubMed ID: 9744689
[TBL] [Abstract][Full Text] [Related]
7. Halothane: how should it be used in a developing country?
Mahboobi N; Esmaeili S; Safari S; Habibollahi P; Dabbagh A; Alavian SM
East Mediterr Health J; 2012 Feb; 18(2):159-64. PubMed ID: 22571093
[TBL] [Abstract][Full Text] [Related]
8. Liver damage after halothane anaesthesia: analysis of cases in Finnish hospitals in 1972-1981.
Oikkonen M; Rosenberg PH
Ann Chir Gynaecol; 1984; 73(1):28-33. PubMed ID: 6732154
[TBL] [Abstract][Full Text] [Related]
9. [Fatal hepatitis in a young child: probable role of halothane].
Mjahed K; Sadraoui A; Salmi S; Laraki M; Benaguida M
Ann Fr Anesth Reanim; 1997; 16(5):531-3. PubMed ID: 9750609
[TBL] [Abstract][Full Text] [Related]
10. A mouse model of severe halothane hepatitis based on human risk factors.
Dugan CM; MacDonald AE; Roth RA; Ganey PE
J Pharmacol Exp Ther; 2010 May; 333(2):364-72. PubMed ID: 20124411
[TBL] [Abstract][Full Text] [Related]
11. Halothane hepatitis.
Qizilbash AH
Can Med Assoc J; 1973 Jan; 108(2):171-7. PubMed ID: 4684624
[TBL] [Abstract][Full Text] [Related]
12. Halothane induced hepatitis: case report.
Otedo AE
East Afr Med J; 2004 Oct; 81(10):538-9. PubMed ID: 15715133
[TBL] [Abstract][Full Text] [Related]
13. Halothane hepatitis in a South African population--frequency and the influence of gender and ethnicity.
Voigt MD; Workman B; Lombard C; Kirsch RE
S Afr Med J; 1997 Jul; 87(7):882-5. PubMed ID: 9259724
[TBL] [Abstract][Full Text] [Related]
14. Halothane hepatitis: a critical review.
Carney FM; Van Dyke RA
Anesth Analg; 1972; 51(1):135-60. PubMed ID: 4399967
[No Abstract] [Full Text] [Related]
15. Hypothesis: halothane hepatitis--has thymol been overlooked?
Hutter CD
Anaesthesia; 1995 Dec; 50(12):1098. PubMed ID: 8546308
[No Abstract] [Full Text] [Related]
16. [Halothane-induced hepatitis. 8 case reports].
Daghfous R; el Aïdli S; Sfaxi M; Daghfous M; Kastalli S; Sraïri S; Loueslati MH; Belkahia C
Tunis Med; 2003 Nov; 81(11):874-8. PubMed ID: 14986543
[TBL] [Abstract][Full Text] [Related]
17. The uses of error: iatrogenic hepatitis.
Rodés J; Bruguera M
Lancet; 2001 Mar; 357(9258):791. PubMed ID: 11253985
[No Abstract] [Full Text] [Related]
18. Could quinacrine prevent 'halothane hepatitis'?
Karamanakos PN
Acta Anaesthesiol Scand; 2009 Apr; 53(4):547-8. PubMed ID: 19317871
[No Abstract] [Full Text] [Related]
19. Halothane hepatitis.
Neuberger J; Williams R
Dig Dis; 1988; 6(1):52-64. PubMed ID: 3349642
[TBL] [Abstract][Full Text] [Related]
20. Halothane-induced hepatitis: paradigm or paradox for drug-induced liver injury.
Kurth MJ; Yokoi T; Gershwin ME
Hepatology; 2014 Nov; 60(5):1473-5. PubMed ID: 24913773
[No Abstract] [Full Text] [Related]
[Next] [New Search]